100 related articles for article (PubMed ID: 7362994)
1. Incidence of malignant melanoma of the skin.
Evans S
Br Med J; 1980 Feb; 280(6211):403. PubMed ID: 7362994
[No Abstract] [Full Text] [Related]
2. [Morphogenesis and variety of precancerous lesions induced by arsenic].
Hundeiker M; Petres J
Arch Klin Exp Dermatol; 1968 May; 231(4):355-65. PubMed ID: 4235142
[No Abstract] [Full Text] [Related]
3. Pigmented hyperplasia of epidermis following feeding of L-dopa to elderly rats.
Maat B
J Natl Cancer Inst; 1977 May; 58(5):1433-6. PubMed ID: 853529
[TBL] [Abstract][Full Text] [Related]
4. Arsenic as a cause of skin cancer, with notes on its occurrence in Pretoria.
Schulz EJ
S Afr Med J; 1967 Sep; 41(33):819-22. PubMed ID: 6060318
[No Abstract] [Full Text] [Related]
5. [Clinical and histological studies on the problem of drug-induced arsenic tumors].
Ehlers G
Z Haut Geschlechtskr; 1968 Sep; 43(18):763-74. PubMed ID: 4886760
[No Abstract] [Full Text] [Related]
6. [Bronchial carcinoma of occupational origin (apropos of 2 cases)].
Kleisbauer JP; Poirier R; Favre R; Laval P
Mars Med; 1972; 109(11):699-704. PubMed ID: 4662231
[No Abstract] [Full Text] [Related]
7. Evaluation of premalignant and malignant lesions during the induction of mouse melanomas.
Berkelhammer J; Oxenhandler RW
Cancer Res; 1987 Mar; 47(5):1251-4. PubMed ID: 3102042
[TBL] [Abstract][Full Text] [Related]
8. Chemical exposures other than arsenic are probably not important risk factors for squamous cell carcinoma, basal cell carcinoma and malignant melanoma of the skin.
Kennedy C; Bajdik CD; Willemze R; Bouwes Bavinck JN
Br J Dermatol; 2005 Jan; 152(1):194-7. PubMed ID: 15656837
[No Abstract] [Full Text] [Related]
9. Malignant melanoma incidence and association with arsenic.
Philipp R; Hughes AO; Robertson MC; Mitchell TF
Bristol Med Chir J; 1983 Oct; 98(368):165-9. PubMed ID: 6640377
[TBL] [Abstract][Full Text] [Related]
10. [Multiple bowenoid arsenic keratoses].
Leyh F; Rothlaender JP
Derm Beruf Umwelt; 1985; 33(3):99-101. PubMed ID: 4028974
[TBL] [Abstract][Full Text] [Related]
11. DNA repair deficiency leads to susceptibility to develop arsenic-induced premalignant skin lesions.
Banerjee M; Sarma N; Biswas R; Roy J; Mukherjee A; Giri AK
Int J Cancer; 2008 Jul; 123(2):283-287. PubMed ID: 18386817
[TBL] [Abstract][Full Text] [Related]
12. Malignant melanoma and levodopa.
Rosin MA; Braun M
Cutis; 1984 Jun; 33(6):572-4. PubMed ID: 6744949
[TBL] [Abstract][Full Text] [Related]
13. Levodopa therapy and malignant melanoma.
Sober AJ; Wick MM
JAMA; 1978 Aug; 240(6):554-5. PubMed ID: 671667
[TBL] [Abstract][Full Text] [Related]
14. Do polyunsaturated fats predispose to malignant melanoma.
Med J Aust; 1976 Aug; 2(8):319-20. PubMed ID: 995007
[No Abstract] [Full Text] [Related]
15. Levodopa and malignant melanoma.
Robinson E; Wajsbort J; Hirshowitz B
Arch Pathol; 1973 Mar; 95(3):213. PubMed ID: 4686512
[No Abstract] [Full Text] [Related]
16. [Bowen's disease of ocular localization caused by chronic exposure to arsenic].
Jordano J; Carreras B; Serrano D; Guirao A
Rev Clin Esp; 1978 Oct; 151(1):57-61. PubMed ID: 740972
[No Abstract] [Full Text] [Related]
17. Diazepam and malignant melanoma.
Adam S; Vessey M
Lancet; 1981 Dec; 2(8259):1344. PubMed ID: 6118737
[No Abstract] [Full Text] [Related]
18. Is cutaneous malignant melanoma associated with the use of antibacterial soaps?
Arbesman H
Med Hypotheses; 1999 Jul; 53(1):73-5. PubMed ID: 10499830
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous malignant melanoma occurring after cyclosporin A therapy.
Arellano F; Krupp PF
Br J Dermatol; 1991 Jun; 124(6):611. PubMed ID: 2064950
[No Abstract] [Full Text] [Related]
20. Do polyunsaturated fats predispose to malignant melonoma?
Goldrick RB; Goodwin RM; Nestel PJ; Davis NC; Poyser A
Med J Aust; 1976 Jun; 1(26):987-9. PubMed ID: 979775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
